血栓彈力圖市場:按類型、按應用、按最終用戶、按地區 - 規模、份額、展望、機會分析,2022-2030
市場調查報告書
商品編碼
1213967

血栓彈力圖市場:按類型、按應用、按最終用戶、按地區 - 規模、份額、展望、機會分析,2022-2030

Thromboelastography Market, By Type, By Application, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 159 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

血栓彈力圖是一項保護您自己免受嚴重受傷或手術期間發生的嚴重出血的測試。 血栓彈力圖(TEG)是體外綜合分析血小板、□、纖維蛋白原和其他凝血元素之間的關係,在移植、動靜脈畸形手術中應用較多。 血小板圖譜可以評估服用氯□格雷和阿司匹林等抗凝劑的患者的血小板活性。 通過將 TEG 納入麻醉前評估,這成為可能。

市場動態

市場參與者加大開發新技術的力度,預計將在預測期內推動全球血栓彈力圖市場的增長。 例如,2022 年 2 月 20 日,美國國家醫學圖書館發表的一篇文章認為,凝血障礙給耳鼻喉頭頸外科 (ENT) 領域帶來了額外的診斷和治療困難。底部。 高凝和低凝患者的凝血病管理需要仔細考慮止血能力的性質。 粘彈性研究 (VET),例如血栓彈力圖 (TEG) 和旋轉血栓彈力圖 (ROTEM),長期以來一直被用作指導血液成分治療 (BCT) 的方法。 VET 被廣泛用於診斷和管理外傷引起的凝血病和出血狀況。

美國 FDA 等監管機構的新批准率不斷提高,這可能會在預測期內推動全球血栓彈力圖市場的增長。 例如,2021 年 1 月 11 日,雅培是一家從事醫療器械和保健品製造和研究的跨國公司。 雅培 (Abbott) 已獲得 FDA 510(k) 許可,可用於首次針對腦震蕩的快速手持式血液檢測。 雅培的 i-STAT Alinity 手持設備將用於為輕度創傷性腦損傷 (TBI)(稱為腦震盪)提供診斷測試。 插入血漿樣本後 15 分鐘即可獲得測試結果。

研究的主要特徵

  • 本報告對全球血栓彈力圖市場進行了深入分析,包括以 2021 年為基準年的預測期(2022-2030 年)的市場規模(百萬美元)和復合年增長率 (CAGR%)。 .
  • 它揭示了不同細分市場的潛在收入機會,並為該市場概述了一個有吸引力的投資建議矩陣。
  • 它還提供了有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭戰略等方面的重要見解。
  • 它根據以下參數介紹了全球血栓彈力圖市場的主要參與者:公司亮點、產品組合、主要亮點、財務業績和戰略。
  • 本研究涵蓋的主要公司包括樂普醫療科技(北京)有限公司、Render Biotech Co.、Haemonetics Corporation、TA Instruments、HemaCore LLC、5-Diagnostics、Xenometrix AG、Framar Hemologix srl、Instrumentation Laboratory, Medirox AB, Diagnostica Stago, Life Diagnostica, SYCOmed e.K., Nordic Biomarker, and Shenzhen Ultra-Diagnostics Biotec. Co., Ltd.
  • 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。我猜。
  • 本研究報告面向該行業的各種利益相關者,包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
  • 利益相關者可以通過用於分析全球血栓彈力圖市場的各種戰略矩陣來促進他們的決策。

內容

第 1 章目的和先決條件

  • 調查目的
  • 先決條件
  • 縮寫說明

第二章市場展望

  • 報告內容
    • 市場定義和範圍
  • 執行摘要
    • 市場概況:按類型分類
    • 市場概況:按應用分類
    • 市場概況:按最終用戶分類
    • 市場概況:按地區
  • 連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

  • 市場動態
    • 司機
    • 約束因素
    • 商機
  • 影響分析
  • 主要發展狀況
  • 行業趨勢
  • 監管場景
  • 最近的產品批准/發布
  • 害蟲分析
  • 搬運工分析

第 4 章全球血栓彈力圖市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • 對需求的影響
  • 對醫療保健的影響
  • 流行病學

第 5 章全球血栓彈力圖市場類型,2017-2030

  • 標準(高嶺土)
  • 快速 TEG
  • 本地 TEG
  • 肝素□
  • 功能性纖維蛋白原
  • 血小板繪圖

第 6 章全球血栓彈力圖市場:按應用,2017-2030

  • 體外循環
  • 肝臟手術
  • 創傷外科
  • 產科

第 7 章。全球血栓彈力圖市場:按最終用戶分類,2017-2030

  • 醫院
  • 血庫
  • 學術機構
  • 其他(實驗室、研究所)

第 8 章。全球血栓彈力圖市場:地區,2017-2030

  • 北美
  • 美國
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲地區
  • 歐洲
  • 德國
  • 英國
  • 法國
  • 意大利
  • 西班牙
  • 俄羅斯
  • 其他歐洲地區
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 韓國
  • 東盟
  • 其他亞太地區
  • 中東
  • 海灣合作委員會
  • 以色列
  • 其他中東地區
  • 非洲
  • 南非
  • 中非
  • 北非

第9章競爭格局

  • 熱圖分析
  • 市場份額分析
    • Lepu Medical Technology(Beijing)Co.,Ltd.
    • Render Biotech Co.
    • Haemonetics Corporation
    • TA Instruments
    • HemaCore LLC
    • 5-Diagnostics
    • Xenometrix AG
    • Framar Hemologix srl
    • Instrumentation Laboratory
    • Medirox AB
    • Diagnostica Stago
    • Life Diagnostica
    • SYCOmed e.K.
    • Nordic Biomarker
    • Shenzhen Ultra-Diagnostics Biotec. Co., Ltd.

第 10 章

  • 調查方法介紹
  • 關於出版商
簡介目錄
Product Code: CMI2371

The thromboelastography protects against the severe blood loss or hemorrhage occurred during severe injury or during a surgery. Thromboelastography (TEG) is more frequently used in cardiac surgery, organ transplants, and arteriovenous malformation surgeries where the anticipated blood loss is greater than 40% of the circulating blood volume because it performs an in vitro analysis of the relationship between platelets, enzymes, fibrinogen, and other coagulation elements in a comprehensive manner. Through platelet mapping, patients using antiaggregants like clopidogrel or aspirin can have their platelet activity assessed. This is made possible by include TEG in the pre-anesthetic assessment.

Market Dynamics

Increasing initiatives in developing new methods by market players is expected to boost the growth of global thromboelastography market over the forecast period. For instance, on February 20, 2022, an article published in national library of medicine, asserted that Coagulopathies pose additional diagnostic and therapeutic difficulties in the field of otolaryngology-head and neck surgery (ENT). Management of coagulopathies in both hyper- and hypocoagulable individuals necessitates careful consideration of the nature of hemostatic competence. Viscoelastic tests (VETs) such as thromboelastography (TEG) and rotational thromboelastometry (ROTEM) have long been methods of guiding blood component therapy (BCT). VETs have been widely adopted for the diagnosis and management of trauma-induced coagulopathy and bleeding conditions.

Increasing in the rate of new approvals by regulatory authorities such as the U.S. FDA is likely to boost the growth of global thromboelastography market over the forecast period. For instance, on January 11, 2021, Abbott Laboratories is a multinational company engaged in manufacturing and research of medical devices and health care products. Abbott received an FDA 510(k) clearance for the first rapid handheld blood test for concussion. The i-STAT Alinity handheld device from Abbott will be used to provide the test to help diagnose mild traumatic brain injury (TBI), also known as concussion. The test results are available 15 minutes after inserting a plasma sample.

Key features of the study:

  • This report provides an in-depth analysis of the global thromboelastography market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global thromboelastography market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
  • Key companies covered as a part of this study include Lepu Medical Technology (Beijing) Co.,Ltd., Render Biotech Co., Haemonetics Corporation, TA Instruments, HemaCore LLC, 5-Diagnostics, Xenometrix AG, Framar Hemologix srl, Instrumentation Laboratory, Medirox AB, Diagnostica Stago, Life Diagnostica, SYCOmed e.K., Nordic Biomarker, and Shenzhen Ultra-Diagnostics Biotec. Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global thromboelastography market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global thromboelastography market

Detailed Segmentation:

  • Global Thromboelastography Market, by Type:
    • Standard (kaolin)
    • Rapid TEG
    • Native TEG
    • Heparinase
    • Functional Fibrinogen
    • Platelet Mapping
  • Global Thromboelastography Market, by Application :
    • Cardiopulmonary Bypass
    • Liver Surgery
    • Trauma surgery
    • Obstetrics
  • Global Thromboelastography Market, by End User :
    • Hospitals
    • Blood Banks
    • Academic Institutes
    • Others (Research Laboratories, Research Institutes)
  • Global Thromboelastography Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Lepu Medical Technology (Beijing) Co.,Ltd *
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Render Biotech Co.
    • Haemonetics Corporation
    • TA Instruments
    • HemaCore LLC
    • 5-Diagnostics
    • Xenometrix AG
    • Framar Hemologix srl
    • Instrumentation Laboratory
    • Medirox AB
    • Diagnostica Stago
    • Life Diagnostica
    • SYCOmed e.K.
    • Nordic Biomarker
    • Shenzhen Ultra-Diagnostics Biotec. Co., Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunity
  • Impact Analysis
  • Key Developments
  • Industry Trends
  • Regulatory Scenario
  • Recent Product Approval/Launches
  • PEST Analysis
  • Porter's Analysis

4. Global Thromboelastography Market- Impact of Coronavirus (COVID-19) Pandemic

  • Impact on Demand
  • Impact on Healthcare
  • Epidemiology

5. Global Thromboelastography Market, By Type, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Standard (kaolin)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Rapid TEG
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
  • Native TEG
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Heparinase
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Functional Fibrinogen
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
  • Platelet Mapping
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

6. Global Thromboelastography Market, By Application, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Cardiopulmonary Bypass
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Liver Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
  • Trauma surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Obstetrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)

7. Global Thromboelastography Market, By End User, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Blood Banks
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
  • Academic Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Others (Research Laboratories, Research Institutes)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

8. Global Thromboelastography Market, By Region, 2017 - 2030 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030(%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2030
    • Regional Trends
  • North America
    • Market Size and Forecast, By Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • U.S.
  • Canada
  • Latin America
    • Market Size and Forecast, By Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Type, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
    • Market Size and Forecast, By Region/Country, 2017 - 2030 (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Lepu Medical Technology (Beijing) Co.,Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Render Biotech Co.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Haemonetics Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • TA Instruments
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • HemaCore LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • 5-Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Xenometrix AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Framar Hemologix srl
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Instrumentation Laboratory
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Medirox AB
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Diagnostica Stago
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Life Diagnostica
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • SYCOmed e.K.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Nordic Biomarker
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Shenzhen Ultra-Diagnostics Biotec. Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About Us